Pu Xia. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsHumansLipoproteins, HDL/pharmacokineticsLipoproteins, HDL/therapeutic useLysophospholipids/bloodLysophospholipids/pharmacokineticsLysophospholipids/therapeutic useMiceMice, KnockoutReceptors, Lysosphingolipid/deficiencyReceptors, Lysosphingolipid/drug effectsReceptors, Lysosphingolipid/physiologyReperfusion Injury/bloodReperfusion Injury/drug therapySphingosine/analogs & derivativesSphingosine/bloodSphingosine/pharmacokineticsSphingosine/therapeutic use
Substances: See more » Lipoproteins, HDLLysophospholipidsReceptors, Lysosphingolipidsphingosine 1-phosphateSphingosine
Year: 2007 PMID: 17420358 DOI: 10.1161/CIRCULATIONAHA.106.667196
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690